InMode (INMD) Cash & Current Investments (2018 - 2026)
InMode (INMD) posted quarterly Cash & Current Investments of $480.1 million for Q1 2026, up 66.44% year-on-year from $288.5 million in Q1 2025, and up 1.79% on a QoQ basis from $471.7 million in Q4 2025.
InMode (INMD) Cash & Current Investments (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Cash & Current Investments for 9 consecutive years, with $480.1 million the latest figure, recorded in Q1 2026.
- Quarterly Cash & Current Investments rose 66.44% year-over-year to $480.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480.1 million (up 66.44% YoY) and the FY2025 annual result came in at $471.7 million, up 43.47% from the prior year.
- Cash & Current Investments rose to $480.1 million in Q1 2026 per INMD's latest filing, from $471.7 million in the prior quarter.
- Over the last five years, Cash & Current Investments for INMD reached as high as $480.1 million in Q1 2026 and fell as low as $101.1 million in Q1 2022.
- A 5-year average of $300.7 million and a median of $327.3 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2024 — Cash & Current Investments soared 125.01% — and 2025, when it dropped 24.04%.
- Year by year, Cash & Current Investments stood at $172.8 million in 2022, then jumped by 112.95% to $368.0 million in 2023, then declined by 10.65% to $328.8 million in 2024, then surged by 43.47% to $471.7 million in 2025, then increased by 1.79% to $480.1 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $480.1 million, $471.7 million, and $410.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | InMode | 981,130.50 | -479.15 Mn | 61.55 Mn | 480.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 480.13 Mn |
| Dec 31, 2025 | 471.70 Mn |
| Sep 30, 2025 | 410.79 Mn |
| Jun 30, 2025 | 327.30 Mn |
| Mar 31, 2025 | 288.47 Mn |
| Dec 31, 2024 | 328.78 Mn |
| Sep 30, 2024 | 403.43 Mn |
| Jun 30, 2024 | 395.69 Mn |
| Mar 31, 2024 | 379.76 Mn |
| Dec 31, 2023 | 367.96 Mn |
| Sep 30, 2023 | 289.99 Mn |
| Jun 30, 2023 | 228.95 Mn |
| Mar 31, 2023 | 168.78 Mn |
| Dec 31, 2022 | 172.79 Mn |
| Sep 30, 2022 | 151.45 Mn |
| Jun 30, 2022 | 144.32 Mn |
| Mar 31, 2022 | 101.06 Mn |
| Dec 31, 2021 | 121.38 Mn |
| Sep 30, 2021 | 122.15 Mn |
| Jun 30, 2021 | 114.03 Mn |